Compara mètodes

	Monitor Breu de Addiccions (BAM)	Test de Detecció del Trastorn per Ús de Cànnabis	Drug Use Disorders Identification Test (DUDIT)
Camp	Medicina de les addiccions	Medicina de les addiccions	Medicina de les addiccions
Família	Process / pipeline	Process / pipeline	Process / pipeline
Any d'origen	2013	2010	2005
Autor original	Cacciola, Alterman, Drapkin, Valadez	Adamson, Kay-Lambkin, Baker, Lewin, Thornton, Kelly, Sellman	Berman, Bergman, Palmstierna, Schlyter
Tipus	Self-report	Self-report	Self-report
Font seminal	Cacciola, J. S., Alterman, A. I., Drapkin, M. L., & Valadez, C. (2013). Development and initial validation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263.	Adamson, S. J., Kay-Lambkin, F. J., Baker, A. L., Lewin, T. J., Thornton, L., Kelly, B. J., & Sellman, J. D. (2010). An improved brief screening instrument for cannabis use disorder. Drug and Alcohol Dependence, 110(1–2), 55–60.	Berman, A. H., Bergman, H., Palmstierna, T., & Schlyter, F. (2005). Evaluation of the Drug Use Disorder Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research, 11(1), 22–31.
Àlies	BAM	CUDIT-R, CUDIT	DUDIT
Relacionats	4	4	4
Resum	The BAM is a 17-item self-report instrument designed to provide rapid, multimodal assessment of substance use, craving, risk factors, protective factors, and psychosocial functioning in individuals receiving addiction treatment. Developed by Cacciola and colleagues in 2013, it serves as an efficient outcome monitoring tool for tracking treatment progress, identifying relapse warning signs, and guiding therapeutic adjustments. The BAM is useful in treatment settings where frequent assessment of multiple domains is needed to optimize care.	The CUDIT-R is a brief, 8-item self-report screening instrument developed to identify cannabis use disorder and hazardous cannabis use patterns. Introduced by Adamson and colleagues in 2010 as a revision of the original CUDIT, the CUDIT-R improves brevity and screening efficiency while maintaining strong psychometric properties. It is designed for use in primary care, addiction treatment, and public health settings to detect problematic cannabis use and inform treatment allocation decisions.	The DUDIT is a brief, gender-sensitive screening instrument designed to identify individuals with harmful or hazardous drug use patterns across a wide range of substances. Developed by Berman and colleagues in 2005, it serves as a primary care and public health screening tool to detect drug-related problems before they escalate to dependence or disorder. The DUDIT is freely available and has been validated in multiple languages and settings.